PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Immune system discovery reveals potential solution to Alzheimer’s

2025-06-02
(Press-News.org) A new way of thinking about Alzheimer’s disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer’s and other neurodegenerative diseases.

University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful plaques and protein tangles thought responsible for Alzheimer’s. Blocking the molecule protected lab mice from mental decline, the researchers say.

An important player in the brain’s immune system, STING also may be a key contributor to Parkinson’s disease, amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), dementia and other memory-robbing conditions. That means that developing treatments to control its activity could have far-reaching benefits for many patients facing now-devastating diagnoses.

“Our findings demonstrate that the DNA damage that naturally accumulates during aging triggers STING-mediated brain inflammation and neuronal damage in Alzheimer’s disease,” said researcher John Lukens, PhD, director of UVA’s Harrison Family Translational Research Center in Alzheimer’s and Neurodegenerative Diseases. “These results help to explain why aging is associated with increased Alzheimer’s risk and uncover a novel pathway to target in the treatment of neurodegenerative diseases.”

Alarming Trends in Alzheimer’s

Alzheimer’s is a growing problem across the country and around the world: More than 7 million Americans are already living with the condition, and that number could top 13 million by 2050. That has researchers working frantically to find ways to better understand and treat the condition.

The causes of Alzheimer’s remain murky, but scientists are increasingly coming to appreciate the role of the immune system in the disease’s development. STING is part of that immune response; the molecule helps direct the clearance of viruses and stressed cells harboring DNA damage.

While STING is an important defender of the brain, it can also become hyperactive and cause harmful inflammation and tissue damage. That had Lukens and his team eager to determine what part it could be playing in Alzheimer’s. Blocking the molecule’s activity in lab mice, they found, helped prevent Alzheimer’s plaque formation, altered the activity of immune cells called microglia and redirected the workings of important genes, among other effects.

“We found that removing STING dampened microglial activation around amyloid plaques, protected nearby neurons from damage and improved memory function in Alzheimer’s model mice,” said researcher Jessica Thanos, part of UVA’s Department of Neuroscience and Center for Brain Immunology and Glia (BIG Center). “Together, these findings suggest that STING drives detrimental immune responses in the brain that exacerbate neuronal damage and contribute to cognitive decline in Alzheimer’s disease.”

Promising Treatment Target

While scientists have been investigating other molecules thought to be important in Alzheimer’s, STING makes for a particularly attractive target for developing new treatments, the UVA Health researchers say. That’s because blocking STING appears to slow both the buildup of amyloid plaques and the development of tau tangles, the two leading candidates for the cause of Alzheimer’s. Other molecules lack that robust involvement, and, further, could be targeted only at very specific – and very limited – stages in the disease’s progression.

“We are only beginning to understand the complex role of innate immune activation in the brain, and this is especially true in both normal and pathological aging,” Thanos said. “If we can pinpoint which cells and signals sustain that activation, we will be in a much better position to intervene effectively in disease.”

While Lukens’ pioneering research has opened new doors in the fight against Alzheimer’s, much more work will need to be done to translate the findings into treatments. For example, scientists will need to better understand STING’s roles in the body – such as in the immune system’s response to cancer – to ensure any new treatment doesn’t cause unwanted side effects.

But those are the types of big questions that Lukens and his collaborators at the Harrison Family Translational Research Center are eager to tackle as part of their efforts to fast-track new treatments and, eventually, they hope, cures. (The center is part of UVA’s Paul and Diane Manning Institute of Biotechnology, now under construction at Fontaine Research Park.)

“Our hope is that this work moves us close to finding safer and more effective ways to protect the aging brain, as there is an urgent need for treatments that can slow or prevent neuronal damage in Alzheimer’s,” Lukens said. “Shedding light on how STING contributes to that damage may help us target similar molecules and ultimately develop effective disease-modifying treatments.”

Findings Published

The researchers have published their findings in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. The research team consisted of Thanos, Olivia C. Campbell, Maureen N. Cowan, Katherine R. Bruch, Katelyn A. Moore, Hannah E. Ennerfelt, Nick R. Natale, Aman Mangalmurti, Nagaraj Kerur and Lukens. The scientists have no financial interest in the work.

The study was supported by the National Institutes of Health’s National Institute of Aging, grants R01AG071996, R01AG087406 and RF1AG078684; the Alzheimer’s Association, grant ADSF-21-816651; the Cure Alzheimer’s Fund; The Owens Family Foundation; and The Harrison Family Foundation.

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.

END


ELSE PRESS RELEASES FROM THIS DATE:

Salamanders suffering from rising temperatures

2025-06-02
FRANKFURT. Habitat loss, diseases, pollution, and climate change are already massively affecting amphibians – frogs, salamanders, and the caecilians native to tropical regions. The new study from the Institute for Ecology, Evolution and Diversity shows that extreme weather events serve as an additional stress factor, further intensifying this crisis. For this purpose, the scientists analyzed global weather data from the past 40 years. They compared regions with significantly increased heat waves, droughts, and cold spells with the geographical ...

It’s not too late to start eating better for your brain

2025-06-02
As the U.S. population ages and dementia cases rise, many people are asking whether it is possible to prevent this devastating disease. According to a new study, the answer may be on your plate: People who followed a dietary pattern known as the MIND diet were significantly less likely to develop Alzheimer’s disease or related forms of dementia.   The MIND diet, which stands for Mediterranean-DASH Intervention for Neurodegenerative Delay, combines the Mediterranean diet with the blood pressure-lowering DASH (Dietary Approaches to Stop Hypertension) diet and also emphasizes proven brain-healthy ...

Study finds seniors are money savvy – until dementia sets in

2025-06-02
Older adults are quite aware of their financial abilities – and these abilities actually improve with age – that is, until dementia sets in, according to new research from Binghamton University, State University of New York. From paying bills to making change, knowing how to handle money is necessary to live and thrive in society. But what happens as we get older? Do our financial abilities decline and if so, are we even aware of our own shortcomings? To examine this, a team of researchers led by Binghamton University psychologist ...

Synthetic compound shows promise against multidrug resistance

2025-06-02
Highlights: Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments. Researchers have synthesized a new compound called infuzide that shows activity against resistant strains of pathogens. Infuzide works against known, problematic gram-positive pathogens. In lab and mouse tests, infuzide reduced bacterial populations, suggesting it might be useful as a new treatment for drug-resistant infections.  Washington, D.C.—Antimicrobial ...

Researchers recreate ancient Egyptian blues

2025-06-02
PULLMAN, Wash.--A team of Washington State University-led researchers has recreated the world's oldest synthetic pigment, called Egyptian blue, which was used in ancient Egypt about 5,000 years ago. Reporting in the journal, NPJ Heritage Science, the researchers used a variety of raw materials and heating times to develop 12 recipes for the pigments, providing useful information for archaeologists and conservation scientists who study the ancient Egyptian materials. The work was done in collaboration with Carnegie Museum of ...

Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist

2025-06-02
Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery had improved long term survival compared to those who received chemotherapy alone, at 5 years after completing treatment.  Prof. Patrick Forde of the Trinity St. James’s Cancer Institute (TSJCI), Trinity College Dublin School of Medicine presented the findings at the American ...

S2302 Pragmatica-Lung reports out as model for faster, leaner, more representative trials

2025-06-02
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary question, finding that the investigational combination it tested did not significantly extend overall survival compared to standard of care treatments.  Importantly, the phase 3 trial’s rapid development and implementation, coupled with its successful enrollment of a group of patients broadly representative of the larger U.S. population, establish Pragmatica-Lung as a paradigm-shifting model for the design and conduct of future large randomized studies. Results will be presented ...

New Venus observation mission - World's first long-term planetary cubesat study by Korea’s Institute for Basic Science and NanoAvionics

2025-06-02
Daejeon, South Korea, and Vilnius, Lithuania, 2 June 2025 – Kongsberg NanoAvionics (NanoAvionics), a leading small satellite bus manufacturer and mission integrator, has been selected by the Institute for Basic Science (IBS) in South Korea to build the first CubeSat for the world’s first long-term planetary science campaign which will use a series of CubeSats to monitor Venus from low Earth orbit. This long-term Venus observation initiative, the CLOVE project (Chasing the Long-term Variability of Our Nearest Neighbor Planet ...

Brain training game offers new hope for drug-free pain management

2025-06-02
A trial of an interactive game that trains people to alter their brain waves has shown promise as a treatment for nerve pain – offering hope for a new generation of drug-free treatments. The PainWaive technology, developed by UNSW Sydney researchers, teaches users how to regulate abnormal brain activity linked to chronic nerve pain, offering a potential in-home, non-invasive alternative to opioids. A recent trial of the technology, led by Professor Sylvia Gustin and Dr Negin Hesam-Shariati from UNSW Sydney’s NeuroRecovery Research Hub, has delivered promising results, published in the Journal of Pain. The study compared ...

Attachment theory: A new lens for understanding human-AI relationships

2025-06-02
Artificial intelligence (AI) is ubiquitous in this era. As a result, human-AI interactions are becoming more frequent and complex, and this trend is expected to accelerate soon. Therefore, scientists have made remarkable efforts to better understand human-AI relationships in terms of trust and companionship. However, these man-machine interactions can possibly also be understood in terms of attachment-related functions and experiences, which have traditionally been used to explain human interpersonal bonds. In an innovative work, which incorporates two pilot studies and one formal study, a group of researchers from Waseda University, Japan, including Research ...

LAST 30 PRESS RELEASES:

A threesome that hatches potato parasites

Young people discover the technologies shaping their future in the World Economic Forum and Frontiers for Young Minds collection

Real-time 3D visualization reveals potent antibacterial and antibiofilm activity against superbacteria

Abnormal uterine bleeding and insulin resistance are on the rise: Is there a connection?

Eye wear breakthrough: MXene-coated lenses for safer and smarter wearables

‘AI scientist’ suggests combinations of widely available non-cancer drugs can kill cancer cells

Phage therapy at a turning point: Global experts converge in Berlin to shape the future of antimicrobial medicine

Low calorie diets linked to heightened risk of depressive symptoms

Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old

Mum’s obesity linked to child’s heightened hospital admission risk for infection

Millions of new solar system objects to be found and ‘filmed in technicolor’ – studies predict

Pitt study has upended decades-old assumptions about brain plasticity

Hertz Foundation partners with Analog Devices to empower future leaders in analog, digital and software technology solutions

Would you hand over your health data if it meant better care?

Study examines how well wearable tech tracks fitness metrics

Dr. Nikolaos Koundouros wins 2025 Tri-Institutional Breakout Award

Low vs. High blood pressure avoidance in non-cardiac surgery: Neurocognitive outcomes unchanged

Telehealth can improve care for cats with chronic health issues

Researchers develop innovative model to study sense of smell

Birds may be drinking on the wing, but in moderation

Collaboration can unlock Australia’s energy transition without sacrificing natural capital

Study identifies proteins involved in the effectiveness of immunotherapy against blood cancer

Cannabis extract could treat fungal diseases

Pancreatic cancer spreads to liver or lung thanks to this protein

Eating an array of smaller fish could be nutrient-dense solution to overfishing

Han studying potential of next generation telepresence

Emory study finds molecular link between air pollution and pregnancy risks

Controlling bacteria with light: from tackling antibiotic resistance to “bacterial robots”

Johns Hopkins study shows how scientists can use black holes as supercolliders

Being incarcerated and living in areas where more have gone to jail is associated with higher death rates

[Press-News.org] Immune system discovery reveals potential solution to Alzheimer’s